Therefore, COVID-19 patients admitted to the ICU in their study had a significantly higher IL-6 compared to the severe community-acquired pneumonia (COPD) ICU patients, and no difference in serum circulating levels of AAT was observed between them [15]. This evidence concerns the gene IL6 and COVID-19.